CLSA initiated coverage of Cameco (CCJ) with an Outperform rating and $102 price target Cameco, which is already well-positioned with substantial high-quality assets and market share across the nuclear fuel cycle, could “give customers a one-stop shop for the entire nuclear value chain” from mine to reactor, making it “the most comprehensive play for the nuclear rejuvenation theme,” the analyst tells investors. The company’s integrated model should enable Cameco to capitalize on the accelerating global demand for nuclear energy, the analyst argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCJ:
- Nuclear Startup Oklo’s Stock (OKLO) Blasts 1000% in One Year — Time to Buy?
- Cameco price target lowered to C$118 from C$120 at Raymond James
- Cameco price target raised to C$120 from C$110 at BMO Capital
- Cameco production guidance cut ‘immaterial,’ says Cantor Fitzgerald
- Cameco price target raised to $95 from $80 at BofA